# A Comparison of Eleview Versus Hetastarch as Injectate for EMR

> **NCT03350217** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 160 (actual)

## Conditions studied

- Procedural Bleeding
- Delayed Bleeding
- Post-Polypectomy Syndrome
- Post Procedural Complication

## Interventions

- **DRUG:** Eleview
- **DRUG:** Hetastarch

## Key facts

- **NCT ID:** NCT03350217
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-09
- **Primary completion:** 2019-01-07
- **Final completion:** 2019-01-07
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350217, "A Comparison of Eleview Versus Hetastarch as Injectate for EMR". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03350217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*